市場調査レポート

商品コード

1800804

臨床試験用品市場レポート：サービス、フェーズ、治療領域、エンドユーザー産業、地域別、2025～2033年

Clinical Trial Supplies Market Report by Services, Phase, Therapeutic Area (Oncology, Cardiovascular Diseases, Respiratory Diseases, Central Nervous System And Mental Disorders, and Others), End-Use Industry, and Region 2025-2033

出版日: 2025年08月01日
発行: IMARC
ページ情報: 英文 150 Pages
納期: 2～3営業日

カスタマイズ可能

価格

PDF & Excel (Single User License)

USD 2,999 447,600円

レポートPDFおよびExcelを1名のみがご利用頂けるライセンスです。PDFおよびExcel内のテキスト等のコピー&ペースト、印刷はできません。

PDF & Excel (5 User License)

USD 3,999 596,850円

レポートPDFおよびExcelを同一企業内の5名様までがご利用頂けるライセンスです。PDFおよびExcel内のテキスト等のコピー&ペーストはできませんが、印刷は5部まで可能です。印刷したもののご利用はPDFおよびExcelのご利用範囲に準拠します。

PDF & Excel (Corporate License)

USD 4,999 746,100円

レポートPDFおよびExcelを企業内すべての方に使用頂けるライセンスです。PDFおよびExcel内のテキスト等のコピー&ペーストは可能ですが、事前にIMARC Services Private Limited社の許可が必要です。PDFおよびExcelの印刷回数に制限はありません。印刷したもののご利用はPDFおよびExcelのご利用範囲に準拠します。

価格表記: USDを日本円(税抜)に換算

本日の銀行送金レート: 1USD=149.25円

全表示
概要
図表
目次

概要

サンプル依頼リストに入れる

世界の臨床試験用品市場規模は2024年に27億米ドルに達しました。今後、IMARC Groupは、市場は2033年までに47億米ドルに達し、2025年から2033年にかけて6.22%の成長率（CAGR）を示すと予測しています。慢性疾患の有病率の増加、厳しい規制改革、臨床試験の世界化、バイオテクノロジーの進歩、バイオシミラーやオーファンドラッグの出現、サプライチェーン管理へのブロックチェーンやIoTなどの革新的技術の採用などが市場の成長を加速させています。

臨床試験用品は、新薬、治療法、医療機器の安全性と有効性を評価するために、厳密かつ管理された医学実験を実施するために不可欠な幅広い材料とリソースを包含します。臨床試験を円滑に実施する上で極めて重要であり、治療、データ収集、規制基準の遵守に必要なツールや物質を研究者に提供します。臨床試験用品は治験薬、プラセボ、医療機器、生物学的サンプルから構成されます。その用途は、治療効果を評価するためのヒトを対象とした新規治療や介入の試験にまで及ぶ。適切に管理された臨床試験用品の利点には、試験の盲検化を維持する能力、正確なデータ収集の確保、そして最終的には医学知識の向上が含まれます。

世界の臨床試験用品市場は、慢性疾患の有病率の増加や革新的な治療法に対する需要の高まりの影響を受けています。さらに、医薬品開発プロセスの合理化を目的とした規制改革やガイドラインが製薬企業に臨床試験への投資を促し、市場の成長をさらに促進しています。これに伴い、多様な患者集団と費用対効果の高い業務の追求を背景とした臨床試験の世界化が、試験供給に対するより大きなニーズを生み出し、市場の成長を加速させています。さらに、バイオテクノロジーと個別化医療の進歩が臨床試験の複雑性を高め、市場の成長をさらに後押ししています。これとは別に、バイオシミラーや希少疾病用医薬品の出現が臨床試験の範囲を拡大し、市場の成長を後押ししています。

臨床試験用品市場動向と促進要因：

慢性疾患の増加

がん、糖尿病、心血管障害などの慢性疾患の増加は、世界の臨床試験用品市場の重要な促進要因です。人口の高齢化とライフスタイルの変化により、これらの疾患の有病率は世界中で着実に増加しています。その結果、製薬会社は新薬や治療法の開発を余儀なくされ、臨床試験の急増が必要となっています。この動向は、臨床試験用品の需要を煽るだけでなく、これらの健康課題に対処するための効果的かつ効率的な医薬品開発プロセスの緊急性を強調しています。さらに、腫瘍学や神経学のような慢性疾患の特定の治療領域に特化した供給が必要であることも、サプライチェーンの複雑さを助長しており、市場関係者にとって重要な重点分野となっています。

規制改革とガイドライン

世界中の保健当局や機関が発行する規制改革やガイドラインは、臨床試験用品市場を推進する上で極めて重要な役割を果たしています。これらの規制は、患者の安全性を確保しつつ、医薬品開発プロセスを標準化・迅速化することを目的としています。製薬およびバイオテクノロジー分野で事業を展開する企業は、これらのガイドラインを遵守しなければならず、厳格でコンプライアンスに準拠した臨床試験が必要となります。その結果、規制要件を満たす高品質の供給に対する需要が高まっています。このような背景は、厳格な基準を遵守することの重要性を強調するだけでなく、複雑な規制状況をうまく乗り切るための効率的なサプライチェーン管理と文書化の必要性を強調しています。

臨床試験の世界化

臨床試験の世界化は、臨床試験用品市場のもう一つの重要な促進要因です。製薬会社は、多様な患者集団へのアクセス、被験者募集の迅速化、コスト削減のため、複数の国で臨床試験を実施する傾向が強まっています。この動向は、患者数が多い新興市場で特に顕著です。その結果、臨床試験用品の需要は特定の地域に限定されることなく、世界的に拡大しています。このような背景から、規制要件が異なることが多い様々な地域での臨床試験を効率的にサポートできる、堅牢なロジスティクスとサプライチェーンのネットワークの必要性も浮き彫りになっています。さらに、グローバリゼーションは、言語、文化、現地のインフラなどの面で適応性を必要とし、サプライチェーン管理プロセスを複雑にしています。

北米
- 米国
- カナダ
アジア太平洋地域
- 中国
- 日本
- インド
- 韓国
- オーストラリア
- インドネシア
- その他
欧州
- ドイツ
- フランス
- 英国
- イタリア
- スペイン
- ロシア
- その他
ラテンアメリカ
- ブラジル
- メキシコ
- その他
中東・アフリカ

第11章 SWOT分析

第12章バリューチェーン分析

第13章ポーターのファイブフォース分析

第14章競合情勢

市場構造
主要企業
主要企業のプロファイル
- Almac Group Ltd.
- Catalent Pharma Solutions Inc.
- DHL
- Parexel
- Thermo Fisher Scientific Inc.
- PCI Services
- Sharp Clinical
- Biocair
- Movianto

図表

List of Figures

Figure 1: Global: Clinical Trial Supplies Market: Major Drivers and Challenges
Figure 2: Global: Clinical Trial Supplies Market: Sales Value (in Billion USD), 2019-2024
Figure 3: Global: Clinical Trial Supplies Market: Breakup by Services (in %), 2024
Figure 4: Global: Clinical Trial Supplies Market: Breakup by Phase (in %), 2024
Figure 5: Global: Clinical Trial Supplies Market: Breakup by Therapeutic Area (in %), 2024
Figure 6: Global: Clinical Trial Supplies Market: Breakup by End-Use Industry (in %), 2024
Figure 7: Global: Clinical Trial Supplies Market: Breakup by Region (in %), 2024
Figure 8: Global: Clinical Trial Supplies Market Forecast: Sales Value (in Billion USD), 2025-2033
Figure 9: Global: Clinical Trial Supplies (Product Manufacturing) Market: Sales Value (in Million USD), 2019 & 2024
Figure 10: Global: Clinical Trial Supplies (Product Manufacturing) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 11: Global: Clinical Trial Supplies (Packaging, Labeling and Storage) Market: Sales Value (in Million USD), 2019 & 2024
Figure 12: Global: Clinical Trial Supplies (Packaging, Labeling and Storage) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 13: Global: Clinical Trial Supplies (Logistics and Distribution) Market: Sales Value (in Million USD), 2019 & 2024
Figure 14: Global: Clinical Trial Supplies (Logistics and Distribution) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 15: Global: Clinical Trial Supplies (Phase I) Market: Sales Value (in Million USD), 2019 & 2024
Figure 16: Global: Clinical Trial Supplies (Phase I) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 17: Global: Clinical Trial Supplies (Phase II) Market: Sales Value (in Million USD), 2019 & 2024
Figure 18: Global: Clinical Trial Supplies (Phase II) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 19: Global: Clinical Trial Supplies (Phase III) Market: Sales Value (in Million USD), 2019 & 2024
Figure 20: Global: Clinical Trial Supplies (Phase III) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 21: Global: Clinical Trial Supplies (Others) Market: Sales Value (in Million USD), 2019 & 2024
Figure 22: Global: Clinical Trial Supplies (Others) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 23: Global: Clinical Trial Supplies (Oncology) Market: Sales Value (in Million USD), 2019 & 2024
Figure 24: Global: Clinical Trial Supplies (Oncology) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 25: Global: Clinical Trial Supplies (Cardiovascular Diseases) Market: Sales Value (in Million USD), 2019 & 2024
Figure 26: Global: Clinical Trial Supplies (Cardiovascular Diseases) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 27: Global: Clinical Trial Supplies (Respiratory Diseases) Market: Sales Value (in Million USD), 2019 & 2024
Figure 28: Global: Clinical Trial Supplies (Respiratory Diseases) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 29: Global: Clinical Trial Supplies (CNS and Mental Disorders) Market: Sales Value (in Million USD), 2019 & 2024
Figure 30: Global: Clinical Trial Supplies (CNS and Mental Disorders) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 31: Global: Clinical Trial Supplies (Others) Market: Sales Value (in Million USD), 2019 & 2024
Figure 32: Global: Clinical Trial Supplies (Others) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 33: Global: Clinical Trial Supplies (Medical Devices Industry) Market: Sales Value (in Million USD), 2019 & 2024
Figure 34: Global: Clinical Trial Supplies (Medical Devices Industry) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 35: Global: Clinical Trial Supplies (Biopharmaceuticals Industry) Market: Sales Value (in Million USD), 2019 & 2024
Figure 36: Global: Clinical Trial Supplies (Biopharmaceuticals Industry) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 37: Global: Clinical Trial Supplies (Pharmaceuticals Industry) Market: Sales Value (in Million USD), 2019 & 2024
Figure 38: Global: Clinical Trial Supplies (Pharmaceuticals Industry) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 39: Global: Clinical Trial Supplies (Others) Market: Sales Value (in Million USD), 2019 & 2024
Figure 40: Global: Clinical Trial Supplies (Others) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 41: North America: Clinical Trial Supplies Market: Sales Value (in Million USD), 2019 & 2024
Figure 42: North America: Clinical Trial Supplies Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 43: United States: Clinical Trial Supplies Market: Sales Value (in Million USD), 2019 & 2024
Figure 44: United States: Clinical Trial Supplies Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 45: Canada: Clinical Trial Supplies Market: Sales Value (in Million USD), 2019 & 2024
Figure 46: Canada: Clinical Trial Supplies Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 47: Asia Pacific: Clinical Trial Supplies Market: Sales Value (in Million USD), 2019 & 2024
Figure 48: Asia Pacific: Clinical Trial Supplies Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 49: China: Clinical Trial Supplies Market: Sales Value (in Million USD), 2019 & 2024
Figure 50: China: Clinical Trial Supplies Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 51: Japan: Clinical Trial Supplies Market: Sales Value (in Million USD), 2019 & 2024
Figure 52: Japan: Clinical Trial Supplies Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 53: India: Clinical Trial Supplies Market: Sales Value (in Million USD), 2019 & 2024
Figure 54: India: Clinical Trial Supplies Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 55: South Korea: Clinical Trial Supplies Market: Sales Value (in Million USD), 2019 & 2024
Figure 56: South Korea: Clinical Trial Supplies Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 57: Australia: Clinical Trial Supplies Market: Sales Value (in Million USD), 2019 & 2024
Figure 58: Australia: Clinical Trial Supplies Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 59: Indonesia: Clinical Trial Supplies Market: Sales Value (in Million USD), 2019 & 2024
Figure 60: Indonesia: Clinical Trial Supplies Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 61: Others: Clinical Trial Supplies Market: Sales Value (in Million USD), 2019 & 2024
Figure 62: Others: Clinical Trial Supplies Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 63: Europe: Clinical Trial Supplies Market: Sales Value (in Million USD), 2019 & 2024
Figure 64: Europe: Clinical Trial Supplies Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 65: Germany: Clinical Trial Supplies Market: Sales Value (in Million USD), 2019 & 2024
Figure 66: Germany: Clinical Trial Supplies Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 67: France: Clinical Trial Supplies Market: Sales Value (in Million USD), 2019 & 2024
Figure 68: France: Clinical Trial Supplies Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 69: United Kingdom: Clinical Trial Supplies Market: Sales Value (in Million USD), 2019 & 2024
Figure 70: United Kingdom: Clinical Trial Supplies Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 71: Italy: Clinical Trial Supplies Market: Sales Value (in Million USD), 2019 & 2024
Figure 72: Italy: Clinical Trial Supplies Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 73: Spain: Clinical Trial Supplies Market: Sales Value (in Million USD), 2019 & 2024
Figure 74: Spain: Clinical Trial Supplies Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 75: Russia: Clinical Trial Supplies Market: Sales Value (in Million USD), 2019 & 2024
Figure 76: Russia: Clinical Trial Supplies Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 77: Others: Clinical Trial Supplies Market: Sales Value (in Million USD), 2019 & 2024
Figure 78: Others: Clinical Trial Supplies Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 79: Latin America: Clinical Trial Supplies Market: Sales Value (in Million USD), 2019 & 2024
Figure 80: Latin America: Clinical Trial Supplies Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 81: Brazil: Clinical Trial Supplies Market: Sales Value (in Million USD), 2019 & 2024
Figure 82: Brazil: Clinical Trial Supplies Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 83: Mexico: Clinical Trial Supplies Market: Sales Value (in Million USD), 2019 & 2024
Figure 84: Mexico: Clinical Trial Supplies Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 85: Others: Clinical Trial Supplies Market: Sales Value (in Million USD), 2019 & 2024
Figure 86: Others: Clinical Trial Supplies Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 87: Middle East and Africa: Clinical Trial Supplies Market: Sales Value (in Million USD), 2019 & 2024
Figure 88: Middle East and Africa: Clinical Trial Supplies Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 89: Global: Clinical Trial Supplies Industry: SWOT Analysis
Figure 90: Global: Clinical Trial Supplies Industry: Value Chain Analysis
Figure 91: Global: Clinical Trial Supplies Industry: Porter's Five Forces Analysis

List of Tables

Table 1: Global: Clinical Trial Supplies Market: Key Industry Highlights, 2024 and 2033
Table 2: Global: Clinical Trial Supplies Market Forecast: Breakup by Services (in Million USD), 2025-2033
Table 3: Global: Clinical Trial Supplies Market Forecast: Breakup by Phase (in Million USD), 2025-2033
Table 4: Global: Clinical Trial Supplies Market Forecast: Breakup by Therapeutic Area (in Million USD), 2025-2033
Table 5: Global: Clinical Trial Supplies Market Forecast: Breakup by End-Use Industry (in Million USD), 2025-2033
Table 6: Global: Clinical Trial Supplies Market Forecast: Breakup by Region (in Million USD), 2025-2033
Table 7: Global: Clinical Trial Supplies Market: Competitive Structure
Table 8: Global: Clinical Trial Supplies Market: Key Players

Product Code: SR112025A2104

The global clinical trial supplies market size reached USD 2.7 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 4.7 Billion by 2033, exhibiting a growth rate (CAGR) of 6.22% during 2025-2033. Increasing prevalence of chronic diseases, stringent regulatory reforms, the globalization of clinical trials, advancements in biotechnology, the emergence of biosimilars and orphan drugs, and the adoption of innovative technologies like blockchain and IoT for supply chain management are accelerating the market growth.

Clinical trial supplies encompass a wide range of materials and resources essential for conducting rigorous and controlled medical experiments to evaluate the safety and efficacy of new drugs, therapies, or medical devices. They are crucial in ensuring the smooth execution of clinical trials, providing researchers with the necessary tools and substances to administer treatments, collect data, and maintain compliance with regulatory standards. Clinical trial supplies consist of investigational drugs, placebos, medical devices, and biological samples. Their uses extend to the testing of novel treatments and interventions on human subjects to assess their therapeutic effects. Advantages of well-managed clinical trial supplies include the ability to maintain trial blinding, ensuring accurate data collection, and ultimately advancing medical knowledge.

The global clinical trial supplies market is influenced by the increasing prevalence of chronic diseases and the growing demand for innovative therapies. Moreover, regulatory reforms and guidelines aimed at streamlining the drug development process have prompted pharmaceutical companies to invest more in clinical trials, further propelling the market growth. In line with this, the globalization of clinical trials, driven by the pursuit of diverse patient populations and cost-effective operations, has created a greater need for trial supplies, which, in turn, is accelerating the market growth. Additionally, advancements in biotechnology and personalized medicine are increasing the complexity of clinical trials, further boosting the market growth. Apart from this, the emergence of biosimilars and orphan drugs has expanded the scope of clinical trials, which is fueling the market growth.

Clinical Trial Supplies Market Trends/Drivers:

Increasing prevalence of chronic diseases

The rise in chronic diseases, such as cancer, diabetes, and cardiovascular disorders, is a significant driver of the global clinical trial supplies market. With an aging population and shifting lifestyle patterns, the prevalence of these conditions is steadily increasing worldwide. As a result, pharmaceutical companies are compelled to develop new drugs and therapies, necessitating an upsurge in clinical trials. This trend not only fuels the demand for clinical trial supplies but also underscores the urgency for effective and efficient drug development processes to address these health challenges. Furthermore, the need for specialized supplies for specific therapeutic areas within chronic diseases, like oncology or neurology, contributes to the complexity of the supply chain, making it a critical focus area for market players.

Regulatory reforms and guidelines

Regulatory reforms and guidelines issued by health authorities and agencies worldwide play a pivotal role in driving the clinical trial supplies market. These regulations aim to standardize and expedite the drug development process while ensuring patient safety. Companies operating in the pharmaceutical and biotechnology sectors must adhere to these guidelines, necessitating rigorous and compliant clinical trials. As a result, there is a growing demand for high-quality supplies to meet regulatory requirements. This driver not only underscores the importance of adherence to strict standards but also emphasizes the need for efficient supply chain management and documentation to navigate the complex regulatory landscape successfully.

Globalization of clinical trials

The globalization of clinical trials represents another key driver of the clinical trial supplies market. Pharmaceutical companies are increasingly conducting trials in multiple countries to access diverse patient populations, expedite recruitment, and reduce costs. This trend is especially pronounced in emerging markets with significant patient pools. Consequently, the demand for clinical trial supplies is not limited to a specific region but has expanded globally. This driver also highlights the need for robust logistics and supply chain networks that can efficiently support trials conducted in various geographical locations, often with differing regulatory requirements. Furthermore, globalization necessitates adaptability in terms of language, culture, and local infrastructure, adding complexity to the supply chain management process.

Clinical Trial Supplies Industry Segmentation:

Breakup by Services:

Product Manufacturing
Packaging, Labeling and Storage
Logistics and Distribution

Logistics and distribution dominates the market

The logistics and distribution segment within the clinical trial supplies market is witnessing substantial growth due to the increasing globalization of clinical trials. As pharmaceutical companies expand their trials to diverse geographic locations, the need for efficient and reliable logistics and distribution networks becomes paramount. This includes ensuring timely delivery of supplies to various trial sites worldwide. Moreover, advancements in technology, such as the integration of blockchain and IoT, are revolutionizing supply chain management. These innovations enhance real-time tracking and monitoring of clinical trial supplies, leading to increased efficiency and reduced wastage. In line with this, the COVID-19 pandemic has underscored the importance of resilient and adaptable supply chains. Companies are now investing in robust logistics to ensure the uninterrupted flow of critical supplies, even in times of crisis. Furthermore, the emphasis on patient-centric approaches in clinical trials has led to the need for patient kits and direct-to-patient shipments. This trend requires specialized logistics solutions tailored to individual patient needs.

Breakup by Phase:

Phase I
Phase II
Phase III
Others

Phase III dominates the market

The phase III segment dominates the market as it represents the pivotal stage in evaluating a drug's efficacy and safety, making it a critical step in the regulatory approval process. This regulatory focus drives pharmaceutical companies to invest significantly in phase III trials. Moreover, as drugs progress through earlier phases, the sample size required for phase III trials increases substantially, translating into higher demand for clinical trial supplies. Additionally, phase III trials often involve a global patient population, necessitating comprehensive supply chain logistics to ensure the timely delivery of materials to diverse sites. In line with this, the increasing complexity of drug development, particularly in areas like oncology and rare diseases, necessitates larger and more complex phase III trials. This complexity includes the need for specialized supplies, patient-centric approaches, and adaptive trial designs. Furthermore, the demand for phase III trials is influenced by market dynamics, including competition and the need for differentiation in therapeutic areas. Companies seek to demonstrate superior efficacy and safety profiles, making phase III trials a pivotal stage in their product development strategies.

Breakup by Therapeutic Area:

Oncology
Cardiovascular Diseases
Respiratory Diseases
Central Nervous System (CNS) And Mental Disorders
Others

Oncology dominates the market

The oncology segment is experiencing significant growth within the clinical trial supplies market, primarily driven by the escalating global incidence of cancer. With cancer being one of the leading causes of mortality worldwide, pharmaceutical companies are increasingly investing in oncology-focused clinical trials to develop novel therapies and treatments. Moreover, advances in cancer research and the identification of specific biomarkers have led to the development of targeted therapies. This trend has necessitated the need for specialized clinical trial supplies tailored to the unique requirements of oncology trials, such as precision medicine tools and specialized diagnostics. Furthermore, regulatory agencies are expediting approvals for promising oncology drugs, encouraging pharmaceutical companies to accelerate their research efforts. Consequently, there is a growing demand for clinical trial supplies to support these fast-paced trials. Besides this, collaborations between pharmaceutical firms and academic institutions or research organizations are fostering innovation in oncology research. This partnership-driven approach is increasing the scope and complexity of clinical trials, thereby boosting the demand for clinical trial supplies.

Breakup by End-Use Industry:

Medical Device Industry
Biopharmaceuticals Industry
Pharmaceuticals Industry
Others

Pharmaceuticals industry hold the largest share in the market

The pharmaceuticals segment is experiencing substantial growth driven by the increasing global burden of chronic diseases, including cancer, cardiovascular ailments, and diabetes, which has led to a heightened demand for innovative drugs and therapies. Moreover, regulatory reforms and evolving healthcare policies are shaping the industry landscape. Stringent regulations and guidelines, particularly in developed markets, necessitate compliance and adherence to safety standards. This environment promotes innovation and the development of high-quality pharmaceutical products. Furthermore, advancements in biotechnology and genomics have ushered in an era of precision medicine. Tailoring treatments to individual patient profiles is becoming more common, driving research and development efforts in the pharmaceutical sector. Apart from this, the emergence of biosimilars and orphan drugs is expanding the pharmaceutical market's scope. Biosimilars offer cost-effective alternatives to biologics, while orphan drugs target rare diseases, presenting lucrative opportunities for pharmaceutical companies.

Breakup by Region:

North America
- United States
- Canada
Asia Pacific
- China
- Japan
- India
- South Korea
- Australia
- Indonesia
- Others
Europe
- Germany
- France
- United Kingdom
- Italy
- Spain
- Russia
- Others
Latin America
- Brazil
- Mexico
- Others
Middle East and Africa

North America exhibits a clear dominance, accounting for the largest clinical trial supplies market share

The market research report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America represented the largest segment.

North America's clinical trial supplies market is witnessing substantial growth, fueled by the region's well-established pharmaceutical and biotechnology sector, coupled with a robust healthcare infrastructure, creates a conducive environment for clinical trials. Moreover, regulatory agencies like the FDA in the United States have streamlined approval processes, encouraging pharmaceutical companies to conduct trials in the region. In line with this, North America's diverse patient populations and access to specialized healthcare facilities make it an attractive destination for clinical trials across various therapeutic areas. Furthermore, the increasing prevalence of chronic diseases, such as diabetes and cancer, drives the demand for clinical trials to develop innovative treatments. Additionally, the emergence of cutting-edge technologies like genomics and precision medicine is propelling North America's position as a hub for advanced clinical research. The pandemic's impact has also accelerated the adoption of virtual and decentralized trials in the region, further contributing to market growth.

Competitive Landscape:

The competitive landscape of the clinical trial supplies market is characterized by a dynamic interplay of various stakeholders, each contributing to the industry's growth and evolution. Service providers in this sector offer a wide range of solutions, including clinical packaging, labeling, distribution, and logistics services, making it a highly specialized and competitive field. Key players in the market differentiate themselves through their global reach, technological capabilities, regulatory compliance, and ability to cater to diverse therapeutic areas. These companies often form strategic partnerships with pharmaceutical and biotechnology firms to provide end-to-end solutions for clinical trials. In addition to established companies, the market also sees the emergence of niche players focusing on specific areas such as direct-to-patient services, temperature-sensitive logistics, and innovative supply chain technologies. These specialized firms cater to the evolving needs of the industry, offering unique solutions to enhance efficiency and cost-effectiveness. Moreover, the market's competitive landscape is influenced by regulatory changes, as compliance with stringent standards is imperative. This factor underscores the importance of choosing suppliers with a proven track record in maintaining the highest quality and compliance levels.

The report has provided a comprehensive analysis of the competitive landscape in the market. Detailed profiles of all major companies have also been provided. Some of the key players in the market include:

Almac Group Ltd.
Catalent Pharma Solutions Inc.
DHL
Parexel
Thermo Fisher Scientific Inc.
PCI Services
Sharp Clinical
Biocair
Movianto

Key Questions Answered in This Report:

How has the global clinical trial supplies market performed so far, and how will it perform in the coming years?
What are the drivers, restraints, and opportunities in the global clinical trial supplies market?
What is the impact of each driver, restraint, and opportunity on the global clinical trial supplies market?
What are the key regional markets?
Which countries represent the most attractive clinical trial supplies market?
What is the breakup of the market based on the services?
Which are the most attractive services in the clinical trial supplies market?
What is the breakup of the market based on the phase?
Which is the most attractive phase in the clinical trial supplies market?
What is the breakup of the market based on the therapeutic area?
Which is the most attractive therapeutic area in the clinical trial supplies market?
What is the breakup of the market based on end-use industry?
Which is the most attractive end-use industry in the clinical trial supplies market?
What is the competitive structure of the global clinical trial supplies market?
Who are the key players/companies in the global clinical trial supplies market?

1 Preface

2 Scope and Methodology

2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
- 2.3.1 Primary Sources
- 2.3.2 Secondary Sources
2.4 Market Estimation
- 2.4.1 Bottom-Up Approach
- 2.4.2 Top-Down Approach
2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

4.1 Overview
4.2 Key Industry Trends

5 Global Clinical Trial Supplies Market

5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast

6 Market Breakup by Services

6.1 Product Manufacturing
- 6.1.1 Market Trends
- 6.1.2 Market Forecast
6.2 Packaging, Labeling and Storage
- 6.2.1 Market Trends
- 6.2.2 Market Forecast
6.3 Logistics and Distribution
- 6.3.1 Market Trends
- 6.3.2 Market Forecast

7 Market Breakup by Phase

7.1 Phase I
- 7.1.1 Market Trends
- 7.1.2 Market Forecast
7.2 Phase II
- 7.2.1 Market Trends
- 7.2.2 Market Forecast
7.3 Phase III
- 7.3.1 Market Trends
- 7.3.2 Market Forecast
7.4 Others
- 7.4.1 Market Trends
- 7.4.2 Market Forecast

8 Market Breakup by Therapeutic Area

8.1 Oncology
- 8.1.1 Market Trends
- 8.1.2 Market Forecast
8.2 Cardiovascular Diseases
- 8.2.1 Market Trends
- 8.2.2 Market Forecast
8.3 Respiratory Diseases
- 8.3.1 Market Trends
- 8.3.2 Market Forecast
8.4 CNS and Mental Disorders
- 8.4.1 Market Trends
- 8.4.2 Market Forecast
8.5 Others
- 8.5.1 Market Trends
- 8.5.2 Market Forecast

9 Market Breakup by End-Use Industry

9.1 Medical Device Industry
- 9.1.1 Market Trends
- 9.1.3 Market Forecast
9.2 Biopharmaceuticals Industry
- 9.2.1 Market Trends
- 9.2.3 Market Forecast
9.3 Pharmaceuticals Industry
- 9.3.1 Market Trends
- 9.3.2 Market Forecast
9.4 Others
- 9.4.1 Market Trends
- 9.4.3 Market Forecast

10 Market Breakup by Region

10.1 North America
- 10.1.1 United States
  - 10.1.1.1 Market Trends
  - 10.1.1.2 Market Forecast
- 10.1.2 Canada
  - 10.1.2.1 Market Trends
  - 10.1.2.2 Market Forecast
10.2 Asia Pacific
- 10.2.1 China
  - 10.2.1.1 Market Trends
  - 10.2.1.2 Market Forecast
- 10.2.2 Japan
  - 10.2.2.1 Market Trends
  - 10.2.2.2 Market Forecast
- 10.2.3 India
  - 10.2.3.1 Market Trends
  - 10.2.3.2 Market Forecast
- 10.2.4 South Korea
  - 10.2.4.1 Market Trends
  - 10.2.4.2 Market Forecast
- 10.2.5 Australia
  - 10.2.5.1 Market Trends
  - 10.2.5.2 Market Forecast
- 10.2.6 Indonesia
  - 10.2.6.1 Market Trends
  - 10.2.6.2 Market Forecast
- 10.2.7 Others
  - 10.2.7.1 Market Trends
  - 10.2.7.2 Market Forecast
10.3 Europe
- 10.3.1 Germany
  - 10.3.1.1 Market Trends
  - 10.3.1.2 Market Forecast
- 10.3.2 France
  - 10.3.2.1 Market Trends
  - 10.3.2.2 Market Forecast
- 10.3.3 United Kingdom
  - 10.3.3.1 Market Trends
  - 10.3.3.2 Market Forecast
- 10.3.4 Italy
  - 10.3.4.1 Market Trends
  - 10.3.4.2 Market Forecast
- 10.3.5 Spain
  - 10.3.5.1 Market Trends
  - 10.3.5.2 Market Forecast
- 10.3.6 Russia
  - 10.3.6.1 Market Trends
  - 10.3.6.2 Market Forecast
- 10.3.7 Others
  - 10.3.7.1 Market Trends
  - 10.3.7.2 Market Forecast
10.4 Latin America
- 10.4.1 Brazil
  - 10.4.1.1 Market Trends
  - 10.4.1.2 Market Forecast
- 10.4.2 Mexico
  - 10.4.2.1 Market Trends
  - 10.4.2.2 Market Forecast
- 10.4.3 Others
  - 10.4.3.1 Market Trends
  - 10.4.3.2 Market Forecast
10.5 Middle East and Africa
- 10.5.1 Market Trends
- 10.5.2 Market Breakup by Country
- 10.5.3 Market Forecast

11 SWOT Analysis

11.1 Overview
11.2 Strengths
11.3 Weaknesses
11.4 Opportunities
11.5 Threats

12 Value Chain Analysis

13 Porters Five Forces Analysis

13.1 Overview
13.2 Bargaining Power of Buyers
13.3 Bargaining Power of Suppliers
13.4 Degree of Competition
13.5 Threat of New Entrants
13.6 Threat of Substitutes

14 Competitive Landscape

14.1 Market Structure
14.2 Key Players
14.3 Profiles of Key Players
- 14.3.1 Almac Group Ltd.
  - 14.3.1.1 Company Overview
  - 14.3.1.2 Product Portfolio
  - 14.3.1.3 Financials
  - 14.3.1.4 SWOT Analysis
- 14.3.2 Catalent Pharma Solutions Inc.
  - 14.3.2.1 Company Overview
  - 14.3.2.2 Product Portfolio
- 14.3.3 DHL
  - 14.3.3.1 Company Overview
  - 14.3.3.2 Product Portfolio
  - 14.3.3.3 Financials
- 14.3.4 Parexel
  - 14.3.4.1 Company Overview
  - 14.3.4.2 Product Portfolio
  - 14.3.4.3 SWOT Analysis
- 14.3.5 Thermo Fisher Scientific Inc.
  - 14.3.5.1 Company Overview
  - 14.3.5.2 Product Portfolio
  - 14.3.5.3 Financials
  - 14.3.5.4 SWOT Analysis
- 14.3.6 PCI Services
  - 14.3.6.1 Company Overview
  - 14.3.6.2 Product Portfolio
- 14.3.7 Sharp Clinical
  - 14.3.7.1 Company Overview
  - 14.3.7.2 Product Portfolio
- 14.3.8 Biocair
  - 14.3.8.1 Company Overview
  - 14.3.8.2 Product Portfolio
  - 14.3.8.3 Financials
- 14.3.9 Movianto
  - 14.3.9.1 Company Overview
  - 14.3.9.2 Product Portfolio

臨床試験用品市場レポート：サービス、フェーズ、治療領域、エンドユーザー産業、地域別、2025～2033年

Clinical Trial Supplies Market Report by Services, Phase, Therapeutic Area (Oncology, Cardiovascular Diseases, Respiratory Diseases, Central Nervous System And Mental Disorders, and Others), End-Use Industry, and Region 2025-2033

臨床試験用品市場動向と促進要因：

目次

第1章 序文

第2章 調査範囲と調査手法

第3章 エグゼクティブサマリー

第4章 イントロダクション

第5章 世界の臨床試験用品市場

第6章 市場内訳：サービス別

第7章 市場内訳：フェーズ別

第8章 市場内訳：治療領域別

第9章 市場内訳：エンドユーザー産業別

第10章 市場内訳：地域別

第11章 SWOT分析

第12章 バリューチェーン分析

第13章 ポーターのファイブフォース分析

第14章 競合情勢